S
Summit Therapeutics Inc. (SMMT)
NGM – Real Time Price. Currency in USD
15.10
-0.01 (-0.10%)
At close: Aug 12, 2026, 4:00 PM EDT
15.13
+0.03 (0.20%)
After-hours: Aug 12, 2026, 5:45 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NGM – Real Time Price. Currency in USD
15.10
-0.01 (-0.10%)
At close: Aug 12, 2026, 4:00 PM EDT
15.13
+0.03 (0.20%)
After-hours: Aug 12, 2026, 5:45 PM EDT
No Data
There are no news for this stock.
Company's cash reserves $419.7M significantly exceed its total debt $20.4M, ensuring strong financial flexibility
Total current assets $720.6M exceed Total current liabilities $103.6M, highlighting excellent liquidity
Debt-to-equity ratio (0.0) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$141.5M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.96 | 6.05 | 10 | |
| Quick ratio | 6.96 | 5.63 | 10 | |
| Debt to Equity | 0.03 | 0.30 | 9.0 | |
| Debt to Assets | 0.03 | 1.04 | 9.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.8 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 705K | N/A | N/A | N/A | N/A |
| Gross Profit | -2M | -2M | -89K | -146K | -174K |
| Operating Income | -79M | -90M | -211M | -1.09B | -875M |
| Net Income | -79M | -615M | -221M | -1.08B | -856M |
| EBITDA | -77M | -88M | -211M | -1.09B | -875M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 9.87 | 3.5 |
| Next quarter | N/A | -20.06 | 1.0 |
| Current year | N/A | 21.79 | 5.5 |
| Next year | 1525.79 | 1.9 | 6.5 |
| Weighted average score | 4.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -13.86 | -16.66 | -15.43 | 3.3 |
| Y/Y | 999 | 61.87 | 63.16 | -100.54 | 7.8 |
| 3y average | 632.67 | -334.76 | -145.9 | -98.2 | 3.3 |
| 5y average | 389.47 | -212.26 | -81.34 | -60.53 | 3.3 |
| Weighted average score | 4.4 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | Medium | 7.0 |
| Switching costs | Medium | 5.0 |
| Network effect | None | 1.0 |
| Economies of scale | Narrow | 3.0 |
| Weighted average score | 3.4 | |